Je veux savoir à propos de…

38492

Federal Register / Vol. 86, No. 137 / Wednesday, July 21, 2021 / Notices
3 Agency management and supervisory costs, 4 Costs of enforcement, research, and establishment of regulations and guidance, 5 Use of electronic data processing equipment to collect and maintain informationthe actual cost of the service, including computer search time, runs and printouts, and 6 Any other direct or indirect costs related to the provision of services.
The Department will continue to review the user fees periodically as required by Office of Management and Budget Circular Number A25 and will revise fees as necessary. Any future changes in user fees and their effective dates will be announced in the Federal Register.
Diana Espinosa, Acting Administrator.
FR Doc. 202115514 Filed 72021; 8:45 am BILLING CODE 416515P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Twelfth Meeting of the National Clinical Care Commission Office on Womens Health, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.
ACTION: Notice.
AGENCY:

The National Clinical Care Commission the Commission will conduct its twelfth and final meeting virtually on September 8, 2021. The Commission is charged to evaluate and make recommendations to the U.S.
Department of Health and Human Services HHS Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to diabetes and its complications.

SUMMARY:

The final meeting will take place September 8, 2021 from 1 p.m. to approximately 6 p.m. Eastern Time ET.
ADDRESSES: The meeting will be held online via webinar. To register to attend the meeting, please visit the registration website at https
kauffmaninc.adobeconnect.com/
nccc12_2021/event/event_info.html.
FOR FURTHER INFORMATION CONTACT: Kara Elam, Ph.D., MPH, MS, Designated Federal Officer, National Clinical Care Commission, U.S. Department of Health and Human Services, Office on Womens Health, 200 Independence Ave. SW, 7th floor, Washington DC,
jbell on DSKJLSW7X2PROD with NOTICES

DATES:

VerDate Sep<11>2014

17:26 Jul 20, 2021

Jkt 253001

20201, Phone: 240 4359438, Email:
Kara.Elam@hhs.gov.
SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act Pub. L. 11580 requires the HHS
Secretary to establish the National Clinical Care Commission. The Commission consists of representatives of specific federal agencies and nonfederal individuals who represent diverse disciplines and views. The Commission will evaluate and make recommendations to the HHS Secretary and Congress regarding improvements to the coordination and leveraging of federal programs related to diabetes and its complications.
During the meeting, the Commission will vote to approve the final report to be submitted to Congress. The final meeting agenda will be available prior to the meeting at https health.gov/ourwork/health-care-quality/nationalclinical-care-commission/meetings.
Public Participation at Meeting: The Commission invites public comment on issues related to the Commissions charge. There will be an opportunity for limited oral comments each no more than 3 minutes in length at this virtual meeting. Virtual attendees who plan to provide oral comments at the Commission meeting during a designated time must register prior to the meeting at https
kauffmaninc.adobeconnect.com/
nccc12_2021/event/event_info.html.
Written comments are welcome throughout the entire development process of the Commissions work and may be emailed to OHQ@hhs.gov.
Written comments should not exceed three pages in length.
Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate the special accommodation when registering online or by notifying Jennifer Gillissen at jennifer.gillissen@
kauffmaninc.com by August 30, 2021.
Authority: The National Clinical Care Commission is required under the National Clinical Care Commission Act Pub. L. 11580. The Commission is governed by provisions of the Federal Advisory Committee Act FACA, Public Law 92463, as amended 5 U.S.C., App. which sets forth standards for the formation and use of federal advisory committees.
Dated: July 14, 2021.
Dorothy A. Fink, Deputy Assistant Secretary for Womens Health.
FR Doc. 202115507 Filed 72021; 8:45 am BILLING CODE 415032P

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis Panel; Clinical Courses.
Date: August 30, 2021.
Time: 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 Video Meeting.
Contact Person: Greg Bissonette, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Gateway Building, Suite 2W200, Bethesda, MD 20892, 3014021622, bissonettegb@
mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS
Dated: July 15, 2021.
Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202115450 Filed 72021; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose
E:FRFM21JYN1.SGM

21JYN1